Deciphering antibody affinity maturation with language models and weakly supervised learning
In response to pathogens, the adaptive immune system generates specific antibodies that bind and neutralize foreign antigens. Understanding the composition of an individual's immune repertoire can provide insights into this process and reveal potential therapeutic antibodies. In this work, we explore the application of antibody-specific language models to aid understanding of immune repertoires. We introduce AntiBERTy, a language model trained on 558M natural antibody sequences. We find that within repertoires, our model clusters antibodies into trajectories resembling affinity maturation. Importantly, we show that models trained to predict highly redundant sequences under a multiple instance learning framework identify key binding residues in the process. With further development, the methods presented here will provide new insights into antigen binding from repertoire sequences alone.
Code (1)
Tasks
Language ModelingLanguage ModellingMultiple Instance LearningWeakly-supervised LearningSimilar Papers 제목 키워드 기반
Benchmark for Antibody Binding Affinity Maturation and Design
We introduce AbBiBench (Antibody Binding Benchmarking), a benchmarking framework for antibody binding affinity maturation and design. Unlike existing antibody evaluation strategies that rely on antibody alone and its sim…
BenchmarkingAffinityFlow: Guided Flows for Antibody Affinity Maturation
Antibodies are widely used as therapeutics, but their development requires costly affinity maturation, involving iterative mutations to enhance binding affinity.This paper explores a sequence-only scenario for affinity m…
Physical epistatic landscape of antibody binding affinity
Affinity maturation produces antibodies that bind antigens with high specificity by accumulating mutations in the antibody sequence. Mapping out the antibody-antigen affinity landscape can give us insight into the access…
SpecificitySequence-based deep learning antibody design for in silico antibody affinity maturation
Antibody therapeutics has been extensively studied in drug discovery and development within the past decades. One increasingly popular focus in the antibody discovery pipeline is the optimization step for therapeutic lea…
Computational EfficiencyDrug DiscoveryPredictionSpecificityThe weakest link bridging germinal center B cells and follicular dendritic cells limits antibody affinity maturation
The affinity of antibodies (Abs) produced in vivo for their target antigens (Ags) is typically well below the maximum affinity possible. Nearly 25 years ago, Foote and Eisen explained how an 'affinity ceiling' could aris…